Interna Therapeutics, a clinical stage biotechnology company advancing its Molecular Nano Motor (MNM) intracellular delivery platform, today announced a research collaboration with Daiichi Sankyo (TSE ...
Daiichi Sankyo has signed a research partnership with Interna Therapeutics to develop targeted delivery solutions based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results